Atlas Trials

Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety

Clinical trial NCT00004373 · COMPLETED

Trial details

NCT number
NCT00004373
Sponsor
National Institute on Drug Abuse (NIDA)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Anxiety DisorderPanic Disorder
Start date
1997-03-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.